| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/26/2007 | US20070172523 Soft-gelatin capsule formulation |
| 07/26/2007 | US20070172522 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 07/26/2007 | US20070172518 Method of making silicone pressure sensitive adhesives for delivering hydrophilic drugs |
| 07/26/2007 | US20070172517 Compositions capable of facilitation penetration across a biological barrier |
| 07/26/2007 | US20070172514 Materials and methods for improving livestock productivity |
| 07/26/2007 | US20070172511 Food Products Comprising a Slowly Digestible or Digestion Resistant Carbohydrate Composition |
| 07/26/2007 | US20070172510 Nutrients to enhance performance; fuel for body; mixture of nutraceuticals and caffeine |
| 07/26/2007 | US20070172509 Drug Delivery System for Retarding Release of Water Soluble Drugs |
| 07/26/2007 | US20070172508 Transluminal drug delivery methods and devices |
| 07/26/2007 | US20070172507 Transluminal drug delivery methods and devices |
| 07/26/2007 | US20070172480 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 07/26/2007 | US20070172471 Method for identifying an anti- streptococcal agent and its use for treating streptococcal infections |
| 07/26/2007 | US20070172469 Methods For Inhibiting Viral Replication In Vivo |
| 07/26/2007 | US20070172468 Dietary supplements for reducing cholesterol levels |
| 07/26/2007 | US20070172467 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin |
| 07/26/2007 | US20070172449 TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
| 07/26/2007 | US20070172447 Agent for preventing and/or treating tissue disruption-accompanied diseases |
| 07/26/2007 | US20070172445 Chronic articular inflammation-modulating composition based on collagen-polyvinylpyrrolidone |
| 07/26/2007 | US20070172444 Hair tonics and method of screening the same |
| 07/26/2007 | US20070172442 Topical compositions associating sodium hyaluronate fragments and retinoid useful for cosmetic and medical dermatology |
| 07/26/2007 | US20070172441 Cation-modified purified galactomannan polysaccharide and cosmetic composition containing the substance |
| 07/26/2007 | US20070172436 Nonaqueous ascorbic acid compositions and methods for preparing same |
| 07/26/2007 | US20070172435 Medicament for internal application, in particular against cancerous diseases |
| 07/26/2007 | US20070172433 Biometic compounds containing hydroxyapatites substituted with magnesium and carbonate, and the processes used to obtain them |
| 07/26/2007 | US20070172421 Substituted pyrrolidine-2-ones |
| 07/26/2007 | US20070172420 Ligands |
| 07/26/2007 | US20070172385 For the prophylaxis or therapy of a clinical condition for which a selective beta 2-adrenoreceptor agonist is indicated, for example asthma or chronic obstructive pulmonary disease (COPD) |
| 07/26/2007 | DE202007006374U1 Venentherapeutische Zubereitung und Herstellung dieser Zubereitung Veins Therapeutic preparation and production of this preparation |
| 07/26/2007 | DE202006019887U1 Medikament zur Behandlung von viszeralem Schmerz Drug for the treatment of visceral pain |
| 07/26/2007 | DE10303229B4 Ambroxol und Inhibitoren des Angiotensin Converting-Enzyms (ACE) umfassende Arzneimittel Arzneimittel-Zubereitung und ihre Verwendung zur Behandlung von neurodegenerativen Erkrankungen Ambroxol and inhibitors of the angiotensin converting enzyme (ACE) pharmaceutical compositions comprising drug preparation and their use for the treatment of neurodegenerative diseases |
| 07/26/2007 | DE102006003509A1 Kontrazeptivum Contraceptive |
| 07/26/2007 | DE102006003508A1 Arzneimittel umfassend eine Hormonkombination A pharmaceutical composition comprising a combination hormone |
| 07/26/2007 | DE102005059222A1 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen 11ß-Benzaldoximderivate of D-Homoestra-4,9-dien-3-ones |
| 07/26/2007 | CA2672094A1 Methods and apparatus for identifying subject matter in view data |
| 07/26/2007 | CA2639921A1 Microspheres comprising nanocapsules containing a lipophilic drug |
| 07/26/2007 | CA2639904A1 Use of mimosine or a derivative thereof for treating the cutaneous effects of psoriasis and related skin disorders, and cosmetic or pharmaceutical composition containing same |
| 07/26/2007 | CA2638107A1 Spiro compounds and methods of use |
| 07/26/2007 | CA2638034A1 A lyophilized solid taxane composition, a process for preparing said solid composition, a pharmaceutical formulation and a kit of said formulation |
| 07/26/2007 | CA2637893A1 Taxane pharmaceutical formulation, solid taxane composition, method for preparing the solid taxane composition, composition for solubilising said solid taxane composition and set of elements (kit) for the injectable taxane formulation |
| 07/26/2007 | CA2637838A1 Novel solid forms of (4r)-1-¬4-(2-chloro-5-fluorobenzoyl)amino-3-methoxybenzoyl|-1,2,3,5-tetrahydro-spiro¬4h-1-benzazepine-4,1'-¬2|cyclopentene|-3'-carboxylic acid |
| 07/26/2007 | CA2637755A1 Dosage form and method for the delivery of drugs of abuse |
| 07/26/2007 | CA2637739A1 Pharmaceutical composition comprising a protein pump inhibitor and protein component |
| 07/26/2007 | CA2637674A1 2-imino-benzimidazoles |
| 07/26/2007 | CA2637635A1 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier |
| 07/26/2007 | CA2637631A1 Pyrimidine compounds and uses thereof |
| 07/26/2007 | CA2637608A1 Method of treating atrophic vaginitis |
| 07/26/2007 | CA2637590A1 Treatment of inflammatory disorders with triazole compounds |
| 07/26/2007 | CA2637575A1 Multi-parameter monitoring device for use with central and intravenous administration of medication |
| 07/26/2007 | CA2637572A1 Piperazine derivatives as farnesyl protein transferase inhibitors |
| 07/26/2007 | CA2637459A1 Substituted 4-phenylpiperidines |
| 07/26/2007 | CA2637458A1 Use of a combination of morphine and at least one opiate antagonist to treat opiate dependency and prevent non-oral opiate abuse among opiate addicts |
| 07/26/2007 | CA2637449A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | CA2637444A1 Coated pharmaceutical composition of tolterodine or a salt thereof having rapid dissolution at acidic conditions and slow dissolution at higher ph values |
| 07/26/2007 | CA2637417A1 Novel indoloquinoxaline derivatives and their use in the treatment of viral infections |
| 07/26/2007 | CA2637408A1 Foam-forming composition |
| 07/26/2007 | CA2637387A1 Specific therapy using integrin ligands for treating cancer |
| 07/26/2007 | CA2637385A1 Compounds for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637359A1 Central administration of stable formulations of therapeutic agents for cns conditions |
| 07/26/2007 | CA2637245A1 Inhibitors of tnf.alpha., pde4 and b-raf, compositions thereof and methods of use therewith |
| 07/26/2007 | CA2637243A1 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 07/26/2007 | CA2637240A1 Pharmaceutical valatograst compositions and process for manufacturing same |
| 07/26/2007 | CA2637205A1 Therapy-enhancing glucan |
| 07/26/2007 | CA2637198A1 Hydantoin compounds for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637196A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 07/26/2007 | CA2637062A1 Neuronal nicotinic receptor ligands and their use |
| 07/26/2007 | CA2637052A1 Dicarbonylic compounds with antibacterial activity |
| 07/26/2007 | CA2637044A1 Xenohormesis based compositions and methods |
| 07/26/2007 | CA2636993A1 Pyrimidine derivatives used as pi-3 kinase inhibitors |
| 07/26/2007 | CA2636992A1 Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof |
| 07/26/2007 | CA2636954A1 Solid forms of a pyrrolopyrimidine derivative and their use as anti-tumor agents |
| 07/26/2007 | CA2636916A1 Methods for treating hepatitis c |
| 07/26/2007 | CA2636909A1 Inhibition of inflammatory cytokine production with tanshinones |
| 07/26/2007 | CA2636905A1 Methods for treating hepatitis c |
| 07/26/2007 | CA2636824A1 Cis-4,5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors |
| 07/26/2007 | CA2636692A1 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 07/26/2007 | CA2636644A1 The use of memantine and brimonidine to attenuate vitreoretinal vascular endothelial growth factor (vegf) protein levels in animals |
| 07/26/2007 | CA2636634A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/26/2007 | CA2636599A1 Modified macromolecule |
| 07/26/2007 | CA2636583A1 2,5-diaza-bicyclo[2.2.1]heptane derivatives as calcium channel blockers |
| 07/26/2007 | CA2636436A1 Long term treatment of hiv- infection with tmc278 |
| 07/26/2007 | CA2636189A1 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | CA2636120A1 Chemical compounds |
| 07/26/2007 | CA2636112A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine derivatives useful for the treatment of alzheimer's disease via gaba receptors |
| 07/26/2007 | CA2636007A1 Sulfonyl substituted 1h-indoles as ligands for the 5-hydroxytryptamine receptors |
| 07/26/2007 | CA2635907A1 Compositions comprising kakadu plum extract or acai berry extract |
| 07/26/2007 | CA2635899A1 Fused heterobicyclic kinase inhibitors |
| 07/26/2007 | CA2635830A1 Thiazole derivatives and use thereof |
| 07/26/2007 | CA2635723A1 Therapeutic uses of inhibitors of rtp801 |
| 07/26/2007 | CA2635691A1 Combination therapy with parp inhibitors |
| 07/26/2007 | CA2635251A1 Stable therapeutic formulations |
| 07/26/2007 | CA2635015A1 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2633774A1 Use of alkanedicarboxylic acids and retinoids for treatment of rosacea and other inflammatory skin diseases |
| 07/26/2007 | CA2633761A1 Treatment of substance abuse |
| 07/26/2007 | CA2633329A1 Pyridine derivatives as sodium channel modulators |
| 07/26/2007 | CA2633100A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2631876A1 Aminophenyl derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2631874A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2631504A1 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 07/26/2007 | CA2630717A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 07/26/2007 | CA2630273A1 Heterocyclylalkyl derivatives as inhibitors of histone deacetylase |